FDA Inspection 1063523 — Shanghai Hengrui Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shanghai Hengrui Pharmaceutical Co., Ltd. on Jul 20, 2018 in Shanghai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 20, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shanghai (China)